TY  - GEN 
AU  - Dash, Sweta
AU  - Hanson, Sabrina
AU  - King, Ben
AU  - Nyswaner, Katherine
AU  - Foss, Kelcie
AU  - Tesi, Noelle
AU  - Harvey, Mungo J.B.
AU  - Navarro Marchal, Saul Abenhamar
AU  - Woods, Alison
AU  - Poradosu, Enrique
AU  - Unciti-Broceta, Asier
AU  - Carragher, Neil O.
AU  - Brognard, John
PY  - 2024
UR  - https://hdl.handle.net/10481/94715
AB  - NXP900 is a selective and potent SRC family kinase (SFK) inhibitor, currently being dosed in a phase 1 clinical trial, that locks SRC in the "closed" conformation, thereby inhibiting both kinase-dependent catalytic activity and kinase-independent...
LA  - eng
PB  - Elsevier
KW  - ESCC
KW  - HNSCC
KW  - Src family kinases
TI  - The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas
DO  - 10.1016/j.jbc.2024.107615
ER  -